Background: Previous studies examining sex-based disparities in emergency department (ED) pain care have been limited to a single pain condition, a single study site, and lack rigorous control for confounders.
D ifferences in pain treatment such as oligoanalgesia, delays in pain assessment, and delays in treatment have been found across several settings. 1 These differences have been attributed to patient characteristics (such as age, [2] [3] [4] sex, 5 race 6 ), institution, 7 physician characteristics (sex and clinical experience 8 ), triage acuity, 9 and emergency department (ED) crowding. 2, 4, [10] [11] [12] [13] [14] [15] In 2014, in response to concerns that women experience more severe acute and chronic pain, a commission formed by the Society of Academic Emergency Medicine investigated sex-based differences in pain treatment. 16 The commission noted a paucity of studies on sex differences in the assessment and treatment of acute pain in the ED. 16 Previous studies have yielded conflicting evidence about the existence of sex-based differences in pain care, 5, 8, [17] [18] [19] but these studies have been limited to a single type of pain (eg, abdominal or back pain), a single study site, or were vulnerable to confounders such as ED crowding. In addition, few studies have examined disparities in the quality of pain treatment in the early hours of the ED visit. Time to pain treatment is an important metric as early analgesia administration has been shown to have an impact on ED outcomes such as length of stay 20 and early pain relief, 21 may improve diagnostic accuracy, 21 and may prevent development of chronic pain. [22] [23] [24] To our knowledge, no multicenter study has examined sex-based disparities in early acute pain care process metrics, and how these early treatment disparities may affect patient pain outcomes.
The objective of this study was to identify sex-based differences in pain treatment processes and patient outcomes. Specifically, this study seeks to assess whether sex differences in delays to analgesics, doses of analgesics, and likelihood of analgesic administration exist, and whether these differences change over time. This study will also examine whether sex differences exist in early ED pain relief (based on a 10-point verbal pain score).
METHODS

Design and Setting
This was a secondary analysis of data from a multicenter cohort of 7082 patient visits collected by Hwang et al 3 for a study on age-related disparities in ED pain care. The cohort includes all adult (18+) patients with fracture pain (FP) or abdominal pain (AP) presenting to 5 geographically distinct hospital EDs in the months of January, April, July, and October 2009 (January 1-31, 2009; April 1-30, 2009;  July 1-31, 2009, and October 1 -31, 2009 ). Four of the EDs were academic centers; 1 was a community hospital. Four of the sites were considered urban, 1 suburban. Two sites were located in the Northeast region of the United States, 1 in the Mid-Atlantic, 1 in the Rocky Mountain Region, and 1 on the West Coast. We excluded visits that did not have time data available or whose time data did not follow a plausible timeline (eg, patients who were recorded to receive an analgesic after ED discharge). This study received institutional board approval with a waiver of informed consent at all 5 sites. For more information about cohort selection by pain condition, please see original study methods. 3 
Variables
The primary patient predictor was sex, which was characterized into men and women. Covariates included in analyses were patient and site-related factors that could affect the quality of pain care received in the ED (based on the literature review or construct validity). These covariates included race/ethnicity, 6 age, 3 sex, 16 Charlson Comorbidity Index, triage acuity, the first recorded pain score, the number of medications patients were taking before the ED visit, and ED occupancy rate (a validated measure of ED crowding 25 ; defined as ED census divided by the number of ED treatment days). Adjusted analyses were clustered by site and also controlled for the type of fracture (long, short, facial bone) and type of AP (nonspecific AP, appendicitis, biliary, bowel obstruction, cancer, colitis, constipation, flank pain, hernia, musculoskeletal, obstetrics/gynecology, pancreatic, urological).
Early Pain Care Process Metrics
To evaluate pain care during the early period of the ED visit, we examined analgesic administration within the first 360 minutes of the ED visit. This period was broken into 90minute intervals and included whether an analgesic was provided, whether an opioid was provided, and the cumulative equianalgesic dose of opioids administered at each interval. Additional treatment processes examined were time to first analgesic order and time to analgesic administration.
Change in Pain Score
All 5 sites used a 10-point verbal rating scale to assess patients' pain. This study examined the change in pain score reported by patients within the first 360 minutes of their ED visit. This was calculated by subtracting the first recorded pain score in the ED (normally recorded during triage) from the pain score at the 360th minute of the ED visit (defined as the last pain score recorded within the first 360 min of the ED visit). Although this outcome measure is novel to this study, the calculation methodology has been used previously to calculate total ED pain score change by subtracting the first recorded pain score from the last recorded pain score before discharge. 3 
Data Collection
The 5 sites in the primary study all had ED electronic medical records (EMRs) (4 used ED Pulsecheck; PICIS Inc., Wakefield, MA and 1 used Epic ASAP: Epic Systems Corp., Verona, WI). The EMRs used at each of the five sites time stamped data as they were entered. Thus time of pain care processes including pain assessments, medication orders and administration, disposition, and discharge are all logged. These time data, together with patient characteristics and pain process data, were abstracted by research personnel trained at each of the 5 sites according to methods established and described by investigators of prior ED pain studies. 2, 4, 10 The abstractors were blinded to the study hypothesis, and were trained using the 12 recommended criteria for medical record review studies. 26 Each abstractor received at least a 4-hour training session, shadowed the chart review process of the investigator, did chart abstractions that were compared with those of the investigators, and were deemed qualified to abstract independently when test abstractions were completed with 95% agreement.
Medications
For our analysis, we considered opioids, acetaminophen, topical anesthetics, and nonsteroidal anti-inflammatory drugs (NSAIDs) as analgesics. Opioids included codeine, fentanyl, hydrocodone, hydromorphone, morphine, methadone as well as combination drugs and opioids such as Percocet (acetaminophen and oxycodone). NSAIDs included ibuprofen, aspirin, indomethacin, naproxen, and ketorolac. Topical anesthetics consisted mainly of topical lidocaine. For patients with AP, proton pump inhibitors, antacids, H1 receptor antagonists, antigas, and phenazopyridine were also considered treatments for AP.
Time Data
Time stamp data from the study were reviewed manually for accuracy and consistency. Patients missing crucial time data (eg, the time of medication administration and order) were excluded from analysis. In addition, any patients with time points that did not adhere to a plausible timeline (eg, recorded as receiving pain medication several days after ED discharge) were removed from the final analysis ( Fig. 1) . For the remaining patients, all pain care processes, medication administration times, and pain scores within the first 90, 180, 270, and 360 minutes from triage were manually filtered and compiled together for further analysis. Analgesic administration in the first 90 minutes has been used as a threshold for evaluation of difference in pain care processes in prior studies, 20 because the literature suggests that up to an 1-hour threshold is a permissible delay in managing severe pain 27, 28 and 90 minutes is the median time to analgesics reported in many EDs. 29, 30 Sensitivity analyses were conducted using 90-minute intervals up to 360 minutes. type of pain (FP vs. AP). Any covariate that could impact the outcome measure based on construct validity or existing evidence in the literature was included in adjusted analysis. Adjusted analyses were completed using generalized estimating equations clustered by study site, using linear models for continuous outcomes, logistic models for categorical outcomes, and gamma with log link function for time-based outcomes. Values reported represent those of adjusted analyses.
RESULTS
Cohort Characteristics
A total of 7082 visits met inclusion criteria (5344 AP, 1738 FP). Of these visits, 6931 (98%) (5249 AP, 1682 FP) had pain care time data and were retained for analyses. The characteristics of this study cohort are listed in Table 1 . There were significant differences by sex in ethnicity, number of prior medications, Charlson Comorbidity Index, and final ED diagnoses of AP or FP (Table 1) .
Analgesic Administration
Analgesic administration varied by sex and pain condition. On adjusted analyses of AP patients, women experienced longer delays to both analgesia ordering and administration ( Table 2) . Consistent with the delay in administration, women were less likely to receive an analgesic up to 180 minutes into the ED visit (OR = 0.906; 95% CI, 0.842-0.974; P = 0.008), but differences were nonsignificant by 270 minutes (OR = 0.969; 95% CI, 0.867-1.082) ( Fig. 2A) . Women were less likely to receive opioids until 180 minutes (OR = 0.872; 95% CI, 0.798-0.951; P = 0.002), but by 270 minutes, there were no statistically significant differences in opioid administration (OR = 0.944; 95% CI, 0.850-1.047) (Fig. 2B ). Women received lower morphine equivalents in the first 90 minutes. This difference in total opioid dose persisted until at least 360 minutes into the ED visit (Fig. 2C) .
In contrast, sex-based differences in pain care processes were not identified in patients with FP. There were no significant differences in the time to first analgesic order (P = 0.133) and administration (P = 0.360) ( Table 2 ). There were no significant sex-based differences in the likelihood of analgesic administration (OR = 1.009; 95 CI, 0.699-1.455; P = 0.357 at 90 min) or dose of opioids in fracture patients (Fig. 2F ).
Pain Scores
When comparing patients with AP by sex, no significant differences were found in final 360-minute pain score (P = 0.210) or the change in pain score after 360 minutes (P = 0.210). Likewise, for FP, no significant differences were found between sexes in the final 360-minute pain score (P = 0.636) or the change in pain score at 360 minutes (P = 0.569) ( Table 3 ).
DISCUSSION
The results of this multicenter observational study suggest that women experienced delays to pain care (rather than a reduction in the overall likelihood of receiving analgesics), and that these differences are condition specific. When patients with AP were analyzed, women were found to have greater delays to both analgesic order and administration. In contrast, when patients with fractures were analyzed, no significant differences were found between sexes in the time to analgesic administration and ordering. The differences in pain care between FP and AP align with the clinical manifestations of these conditions. AP is less overt, can be due to multiple etiologies and, in women, may require additional diagnostic workup such as imaging, pregnancy tests, and pelvic examinations. In addition, the delay in AP medication may be worsened due to a residual belief among some providers that analgesics may decrease diagnostic accuracy of the abdominal examinations. 31 Although no reason exists to delay analgesic administration while awaiting diagnostic workup, it is conceivable that providers may prioritize completion of the extensive workup over proper pain management. In contrast, the workup and treatment of fractures is similar in both sexes; the absence of additional diagnostic evaluation may account for the absence of differences between sexes in time to analgesics.
Our results complement recent studies that have found no sex-based difference in the overall likelihood of analgesic administration in the ED. Banz et al 18 found no difference in the overall likelihood of analgesic reception in a cohort of women arriving to the ED with any type of pain. However, our study is novel in that it examines the first 90 minutes of the ED visit, when disparities do exist, before becoming *Adjusted for race, age, sex, Charlson Comorbidity Index, triage acuity, the first recorded pain score, the number of medications patients were taking before the ED visit, and the type of abdominal pain. GEE were used for multivariable analysis. w Adjusted for race, age, sex, Charlson Comorbidity Index, triage acuity, the first recorded pain score, the number of medications patients were taking before the ED visit, and the type of fracture. GEE were used for multivariable analysis. z Adjusted for race, age, sex, Charlson Comorbidity Index, triage acuity, the first recorded pain score, the number of medications patients were taking before the ED visit, time to first medication order, and the type of abdominal pain. GEE were used for multivariable analysis.
y Adjusted for race, age, sex, Charlson Comorbidity Index, triage acuity, the first recorded pain score, the number of medications patients were taking before the ED visit, time to first medication order, and the type of fracture. GEE were used for multivariable analysis. ED indicates emergency department; GEE, General Estimating Equations.
A B C D E F nonsignificant as the ED visit progresses. This difference in early analgesic administration can likely be explained by the longer delays in analgesic administration to women found by this study. Few studies have specifically examined sex-based analgesia delays. However, our results are consistent with a small study by Chen et al, 5 in which women in a prospective cohort of 75 patients waited 16 minutes longer for analgesics compared with men. Our study also found that women receive lower doses at all times during the first 360 minutes of an ED visit, but this difference may be due to differences in weight-based dosing between sexes.
Our study is novel in that it compares and contrasts management of 2 different types of ED pain conditions at several intervals during an ED visit. These data suggest that different provider-level management regimes for different pain conditions may drive sex disparities in pain care. This study also suggests that sex-based disparities may be hidden if processes are examined of the ED visit as a whole; in our study, pain care disparities differences emerged when the ED visit was examined at each time interval. In an acute care setting such as the ED, early processes may deserve special investigation, as early pain management is an essential function of ED care. 16 This study has several clinical implications. First, delay to analgesia due to long diagnostic workup may be mitigated by operational policies that streamline analgesic administration. Ideally, these interventions should target both medication ordering and administration. For example, nurseinitiated analgesic administration has been shown to reduce time to analgesics by as much as 50%. 32 Second, recognizing that AP in women requires a more comprehensive diagnostic workup, steps may be taken to ensure early initiation of workup. For example, training nursing staff to order imaging at triage has been shown to reduce delays to care by up to 20 minutes. 33 Third, delays to AP medications may be caused by persisting clinician concern that early analgesia sacrifices the accuracy of diagnostic tests (despite evidence to the contrary 34 ). Until recently, for example, a primary surgical textbook advocated holding analgesics until the physical examination was complete. 35 Efforts to improve clinician awareness about the safety and necessity of early analgesics may therefore be a critical target to reduce delays to analgesics. 36 This study is subject to several limitations. First, as it is a retrospective review, this study cannot conclusively determine why sex disparities in early pain treatment exist.
However, 1 reason may be that the more extensive diagnostic workup required for AP in women may contribute to the differences. Second, though this study accounts for several confounders, including ED crowding, triage acuity, comorbidities, and age, it could not control for provider sex. Third, this study cannot account for verbal medication orders (eg, one provider getting the analgesic supplies ready, whereas another places the order in the chart). Finally, the lag time to logging processes of care in the EMR may be influenced by site-level practice variation. For example, at some ERs, nurses may enter medication orders by the bedside, whereas at others they may do it at a central unit. We clustered our analyses by study site to reduce the effects of site-level practice variation on our results. In addition, although the lag time between medication administration and charting of medication administration may vary by site, medication ordering is time-stamped instantaneously. Because medications cannot be administered before the order is placed in an EMR, we believe delays to medication ordering (regardless of the reason) "count" as delays in care.
In conclusion, this is the first multicenter study to evaluate sex-based differences in ED pain care. We found women with AP experienced delays to both medication administration and medication ordering, but not women with fractures. Although sex-based disparities were identified within the first 90 minutes of the ED visit, these differences disappeared by 360 minutes into the ED visit. Despite appearing to wait longer for analgesics, women were, overall, not less likely to receive an analgesic. Future interventions and research into sex-based disparities in pain care should take into account the type of pain condition being treated and address time to analgesic rather than likelihood of receiving analgesic. 
